These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34802445)

  • 1. The CKD bowel health study: understanding the bowel health and gastrointestinal symptom management in patients with chronic kidney disease: a mixed-methods observational longitudinal study (protocol).
    Cooper TE; Dalton A; Kieu A; Howell M; Jayanti S; Khalid R; Lim WH; Scholes-Robertson N; Craig JC; Teixeira-Pinto A; Bourke MJ; Tong A; Wong G
    BMC Nephrol; 2021 Nov; 22(1):388. PubMed ID: 34802445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment decision-making and care among older adults with kidney failure: protocol for a multicentre, prospective observational cohort study with nested substudies and linked qualitative research (the Elderly Advanced CKD Programme).
    Siriwardana A; Gray NA; Makris A; Li CK; Yong K; Mehta Y; Ramos J; Di Tanna GL; Gianacas C; Addo IY; Roxburgh S; Naganathan V; Foote C; Gallagher M
    BMJ Open; 2022 Dec; 12(12):e066156. PubMed ID: 36581411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.
    Kang DW; Adams JB; Gregory AC; Borody T; Chittick L; Fasano A; Khoruts A; Geis E; Maldonado J; McDonough-Means S; Pollard EL; Roux S; Sadowsky MJ; Lipson KS; Sullivan MB; Caporaso JG; Krajmalnik-Brown R
    Microbiome; 2017 Jan; 5(1):10. PubMed ID: 28122648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of symptom burden and its management, in Saudi Arabian patients receiving haemodialysis, and their caregivers: a mixed methods study protocol.
    Alshammari B; Noble H; McAneney H; O'Halloran P
    BMC Nephrol; 2019 Jul; 20(1):250. PubMed ID: 31288747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: A study of uremic enteropathy.
    Grant CJ; Harrison LE; Hoad CL; Marciani L; Gowland PA; McIntyre CW
    J Gastroenterol Hepatol; 2017 Feb; 32(2):372-377. PubMed ID: 27222079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAV-KIDS
    van Zwieten A; Caldwell P; Howard K; Tong A; Craig JC; Alexander S; Howell M; Armando TP; Hawley C; Jesudason S; Walker A; Mackie F; Kennedy S; McTaggart S; McCarthy H; Carter S; Kim S; Crafter S; Woodleigh R; Guha C; Wong G
    BMC Nephrol; 2019 Apr; 20(1):134. PubMed ID: 30999884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
    Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
    Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal complications in patients with chronic kidney disease--a 5-year retrospective study from a tertiary referral center.
    Thomas R; Panackal C; John M; Joshi H; Mathai S; Kattickaran J; Iqbal M
    Ren Fail; 2013; 35(1):49-55. PubMed ID: 23078600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beliefs and Attitudes to Bowel Cancer Screening in Patients with CKD: A Semistructured Interview Study.
    James LJ; Wong G; Craig JC; Ju A; Williams N; Lim WH; Cross N; Tong A
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):568-576. PubMed ID: 28153937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders.
    Ried K; Travica N; Dorairaj R; Sali A
    Nutr Res; 2020 Apr; 76():37-51. PubMed ID: 32151878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study.
    Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G
    BMJ Open; 2021 Feb; 11(2):e042493. PubMed ID: 33593778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
    Bouwmans P; Messchendorp AL; Sanders JS; Hilbrands L; Reinders MEJ; Vart P; Bemelman FJ; Abrahams AC; van den Dorpel MA; Ten Dam MA; de Vries APJ; Rispens T; Steenhuis M; Gansevoort RT; Hemmelder MH;
    BMC Nephrol; 2022 Feb; 23(1):55. PubMed ID: 35123437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-centred approaches for the management of unpleasant symptoms in kidney disease.
    Kalantar-Zadeh K; Lockwood MB; Rhee CM; Tantisattamo E; Andreoli S; Balducci A; Laffin P; Harris T; Knight R; Kumaraswami L; Liakopoulos V; Lui SF; Kumar S; Ng M; Saadi G; Ulasi I; Tong A; Li PK
    Nat Rev Nephrol; 2022 Mar; 18(3):185-198. PubMed ID: 34980890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis.
    Biruete A; Shin A; Kistler BM; Moe SM
    Semin Dial; 2024; 37(4):334-349. PubMed ID: 34708456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of somatic symptom persistence in patients with chronic kidney disease (SOMA.CK): study protocol for a mixed-methods cohort study.
    Shedden-Mora MC; Jessen B; Schmidt-Lauber C; Löwe B; Rösch M; Dannemeyer H; Gloy J; Van den Bergh O; Huber TB
    BMJ Open; 2022 Nov; 12(11):e067821. PubMed ID: 36396319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal symptom burden and dietary intake in patients with chronic kidney disease.
    Meade A; Le Leu R; Watson N; Jesudason S; Clayton P; Faull R; McDonald S; Trimingham C
    J Ren Care; 2021 Dec; 47(4):234-241. PubMed ID: 33931942
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.